Uncategorized
Steel’s Hot Streak Faces Reality Check: Analyst Weighs Tariffs Vs. Recession Fears
Steel prices surged 36% due to tariffs, but real demand hasn’t changed. JPMorgan warns of potential de-stocking & recession risks, adjusts price targets favoring NUE, X, STLD. read more
Trump’s Economic Plan ‘Too Quick’ And ‘Too Painful:’ Economist Warns Stocks Could Drop 30-50% After Monday’s Mayhem
Donald Trump’s economic transition could trigger a 30-50% collapse in stocks and home prices and severe economic turmoil says Craig Shapiro. read more
Novo Nordisk’s Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial
Novo Nordisk’s REDEFINE 2 trial shows CagriSema led to significant weight loss in patients with obesity and type 2 diabetes. Regulatory filing is planned for 2026. read more
Bitcoin’s Heading To $73,000 Without A Fresh Narrative: 10x Research
Bitcoin (CRYPTO: BTC) is on a steady trajectory toward $73,000, but the cryptocurrency market may need a new narrative to spark its next significant upward move, according to < read more
ON Semiconductor Launches Advanced Depth Sensors For Industrial Robotics And Automation
ON Semiconductor’s Hyperlux ID sensors offer enhanced productivity and safety in industries reliant on automation. These sensors track moving objects, improve navigation, and reduce downtime. read more
Nvidia Stock Up 2% After Key Signal Despite Market Sell-off
A significant trading signal occurred for Nvidia stock as it demonstrated a Power Inflow at $106.58, after which NVDA rose up to 2%. read more
EXCLUSIVE: Alzamend Neuro To Launch Phase 2 Study For Lead Drug For PTSD Patients In Late 2025 To Assess Lithium Delivery Benefits
Alzamend Neuro plans a Phase 2 trial of AL001 for PTSD in late 2025, aiming for better lithium delivery, improved safety, and reduced systemic side effects. read more
